股腘段孤立性深静脉血栓:介入与抗凝治疗的系统评价与Meta分析
该系统评价与Meta分析检索PubMed、Embase和Cochrane Library至2018年3月,未发现直接比较经皮腔内静脉介入(PEVI)与全身抗凝治疗股腘段孤立性DVT的研究。另五项回顾性病例系列中两项报告2年通畅率46%-100%。结论认为需更多数据才能确定PEVI应作为首选干预。
要点
- 系统检索未发现直接比较PEVI与抗凝治疗股腘段孤立性DVT的研究。
- 两项回顾性病例系列报告2年通畅率46%-100%。
核心结论
- 需更多数据才能明确PEVI应作为股腘段孤立性DVT的首选干预,尽管初步证据令人鼓舞。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase和Cochrane Library自建库至2018年3月。
- 纳入所有比较PEVI与全身抗凝临床结局的研究。
- 系统检索未发现直接比较PEVI与抗凝治疗股腘段孤立性DVT的研究。
- 传统文献回顾纳入一项随机对照试验和五项回顾性病例系列。
主要发现
- 五项回顾性病例系列包含股腘段孤立性DVT患者,其中两项报告2年通畅率46%-100%。
临床怎么用
- 现有证据尚不足以支持PEVI作为股腘段孤立性DVT的常规首选干预。
局限性
- 系统检索未发现直接比较PEVI与抗凝治疗股腘段孤立性DVT的研究。
- 证据主要来自一项RCT和五项回顾性病例系列,数量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Percutaneous endovenous intervention (PEVI) is gaining acceptance for select patients with symptomatic proximal lower extremity deep venous thrombosis (DVT), but the benefits are uncertain in patients with isolated femoropopliteal DVTs. We performed a systematic review and meta-analysis of the literature to assess the safety and effectiveness of PEVI vs systemic anticoagulation for patients with isolated femoropopliteal DVT. METHODS: We systematically searched PubMed, Embase, and the Cochrane Library from inception to March 2018. All studies comparing clinical outcomes between PEVI and systemic anticoagulation were included. The main end points were post-thrombotic syndrome and bleeding complications. Secondary outcomes included femoropopliteal patency rate, venous obstruction, and recurrent DVT. RESULTS: No studies directly comparing PEVI with systemic anticoagulation in isolated femoropopliteal DVTs were identified by the systematic review. A traditional literature review identified one randomized controlled trial comparing the two, which found no difference in rates of post-thrombotic syndrome in PEVI vs systemic anticoagulation (risk ratio, 0.96; 95% confidence interval, 0.82-1.11; P = .56). We additionally identified five retrospective case series containing patients with isolated femoropopliteal DVTs, of which two reported on patency rates (46%-100% at 2 years). CONCLUSIONS: More data are required to definitively state that PEVI should be the preferred intervention for patients with isolated femoropopliteal DVTs, although the initial evidence is promising.
引用
- Eckenrode G, Baltich Nelson B, Belarmino A, et al. Meta-analysis and systematic review of interventional therapy versus anticoagulation for isolated femoropopliteal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30660583. doi:10.1016/j.jvsv.2018.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。